K Number
K112778
Date Cleared
2011-12-29

(94 days)

Product Code
Regulation Number
892.5050
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Smart Segmentation - Knowledge Based Contouring provides a combined atlas and model based approach for automated and manual segmentation of structures including target volumes and organs at risk to support the radiation therapy treatment planning process.

Device Description

Smart Segmentation - Knowledge Based Contouring is a software only product that provides a combined atlas and model based approach to automated segmentation of structures together with tools for manual contouring or editing of structures. A library of already contoured expert cases is provided which is searchable by anatomy, staging, or free text. Users also have the ability to add or modify expert cases to suit their clinical needs. Expert cases are registered to the target image and selected structures propagated. Smart Segmentation Knowledge Based Contouring supports inter and intra user consistency in contouring. This product also provides an anatomy atlas which gives examples of delineated organs for the whole upper body, as well as anatomy images and functional description for selectable structures. It is not used to simulate plans or calculate dose. The contouring information is exported to the treatment planning software device.

AI/ML Overview

The provided submission K112778 for "Smart Segmentation - Knowledge Based Contouring" does not contain detailed information regarding acceptance criteria, a specific study proving device performance against such criteria, sample sizes for test or training sets, ground truth establishment methods, or information on multi-reader multi-case studies or standalone performance.

The submission focuses on establishing substantial equivalence to predicate devices based on technological characteristics and intended use. It describes the device's functionality and compares it feature-by-feature with existing approved devices.

Therefore, the specific information requested in the prompt cannot be extracted from the provided text. The document primarily acts as a 510(k) summary demonstrating similarities to existing technology rather than presenting a performance study with quantitative acceptance criteria.

{0}------------------------------------------------

K112778

Premarket Notification [510(k)] Summary Smart Segmentation Knowledge Based Contouring

DEC 2 9 2011

The following information is provided following the format of 21 CFR 807.92.

Submitter's Name:Varian Medical Systems, Inc.3100 Hansen Way E-110Palo Alto, CA 94304Contact Name: Vy Tran
Phone: 650/424.5731Fax: 650/842.5040Date: September 2011
Proprietary Name:Smart Segmentation - Knowledge Based Contouring
Classification Name:Medical charged-particle radiation therapy system21 CFR 892.5050, Class IIProduct Code: 90 IYE
Common/Usual Name:Smart Segmentation KBC
Predicate Device:IKOEngelo™ Radiation Therapy Simulation System: (K083591)Eclipse Treatment Planning System: (K071873)
Device Description:Smart Segmentation - Knowledge Based Contouring is a software onlyproduct that provides a combined atlas and model based approach toautomated segmentation of structures together with tools for manualcontouring or editing of structures. A library of already contoured expertcases is provided which is searchable by anatomy, staging, or free text.Users also have the ability to add or modify expert cases to suit theirclinical needs. Expert cases are registered to the target image andselected structures propagated. Smart Segmentation Knowledge BasedContouring supports inter and intra user consistency in contouring. Thisproduct also provides an anatomy atlas which gives examples ofdelineated organs for the whole upper body, as well as anatomy imagesand functional description for selectable structures. It is not used tosimulate plans or calculate dose. The contouring information isexported to the treatment planning software device.
Statement of Intended UseSmart Segmentation - Knowledge Based Contouring provides acombined atlas and model based approach for automated and manualsegmentation of structures including target volumes and organs at riskto support the radiation therapy treatment planning process.
Statement of Indications for Use:Smart Segmentation - Knowledge Based Contouring provides acombined atlas and model based approach for automated and manualsegmentation of structures including target volumes and organs at riskto support the radiation therapy treatment planning process.
Technological Characteristics:Refer to the Substantial Equivalence Comparison Chart

{1}------------------------------------------------

Predicate DeviceIKOEngeloK083591Predicate DeviceEclipse with Smart SegmentationK071873New DeviceSmart Segmentation -Knowledge Based Contouring
General Usage
Support for External beam PHOTON planningyesyesyes
Support for External beam PHOTON inverse planningyesyesyes
Support for External beam ELECTRON planningyesyesyes
Support for External beam PROTON planningyesyesyes
Automated Structure Deliniationyesyesyes
Graphical User Interface
Three View Layoutyesyesyes
Four View Layout (ortho & 3d)noyesyes
3d volume renderingnoyesyes
3d volume MIP renderingnoyesyes
3d volume MIP (rotating) renderingnoyesyes
3d mesh renderingnoyesyes
3d multiplane rendering single imageyesyesyes
3d multiplane rendering blended imagenoyesyes
3d segments renderingyesyesyes
Pixel Info Toolyesyesyes
Distance Toolyesyesyes
Pan Imageyesyesyes
Adjust window / levelyesyesyes
Angle Toolyesyesyes
Area Profile Toolnoyesyes
Histogram Toolyesyesyes
Select Structure Toolyesyesyes
Planar Contour Drawing Toolyesyesyes
Brush Toolyesyesyes
Diffusion Brush Toolnoyesyes
Volumetric Contour Drawing Toolnoyesyes
Deform Structure Toolnonoyes
Image Threshold Toolyesyesyes
PET Subvolume Threshold Toolnoyesyes
Boolean Structure Operationsyesyesyes
Auto Match 3d (rigid)yesyesyes
Manual Match (rigid)yesyesyes
Automatic Deformable Registrationyesnoyes
Region og interest selectionyesyesyes
Structure Editing
Clear Structureyesyesyes
Delete Structureyesyesyes
Delete Structure Setyesyesyes
Copy Structure to registered imageyesyesyes
Duplicate structureyesyesyes
Set Structure Statusnoyesyes
Change Structure IDyesyesyes
Change Structure color & Styleyesyesyes
Show PET Patient Datanoyesyes
Structure Segmentation and Expert Case Selection
Default to algorithm based segmentation for certain structuresnoyes (algorithm based is only option)yes
Expert Case browseryesno*yes
Expert case search - filtersyesno*yes
Expert case search - free text searchnono*yes
Expert case search - add / remove bookmarksyesno*yes
Expert opinion text displayyesno*yes
Add new customer case to databasenono*yes
Modify existing expert case on databasenono*yes
Generate thumbnail preview for expert caseyesno*yes
Anatomy text book displayyesno*yes
Connectivity
DICOM compatibilityyesyesyes

·

:

{2}------------------------------------------------

Note: Eclipse with Smart Segmentation does not have an expert library for structure segmentation

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002

DEC 2 9 2011

Ms. Vy Tran Vice President, Corporate Regulatory Affairs Varian Medical Systems, Inc. 3100 Hansen Way E-110 PALO ALTO CA 94304

Re: K112778

Trade/Device Name: Smart Segmentation-Knowledge Based Contouring Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: IYE Dated: December 13, 2011 · Received: December 16, 2011

Dear Ms. Tran:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

{4}------------------------------------------------

medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Yours,

Mary Pastel

Mary S. Pastel, Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Smart Segmentation Knowledge Based Contouring

Indications for Use

510(k) Number (if known): 上川2778/5001

Smart Segmentation - Knowledge Based Contouring Device Name:

Indications for Use:

Smart Segmentation - Knowledge Based Contouring provides a combined atlas and model based approach for automated and manual segmentation of structures including target volumes and organs at risk to support the radiation therapy treatment planning process.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

Mary Slastel

(Division Sign-Off)
Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety

K112778/5001

ETPS_510(k) _Indications

કારમ

Date: June 30, 2010

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.